Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

MyndYou Collaborates with Mass General Hospital for Research Trial Using MyndYou Platform:

Posted on: 25 Jul 17
MyndYou Collaborates with Mass General Hospital for Research Trial Using MyndYou Platform: Focusing on Quantitative, Objective Assessment of Speech Patterns in Alzheimer's Patients

PR Newswire

TEL AVIV, Israel and BOSTON, July 25, 2017

TEL AVIV, Israel and BOSTON, July 25, 2017 /PRNewswire/ -- MyndYou is pleased to announce a research collaboration with Bradford Dickerson, MD, Department of Neurology and Bonnie Wong, PhD, Department of Psychiatry, both at Massachusetts General Hospital. This research trial will use and validate MyndYou technology for the remote, automated detection of subtle changes in speech patterns of Alzheimer's patients.

Primary Progressive Aphasia (PPA) is a neurodegenerative language disorder arising most often from Frontotemporal Lobar Degeneration (FTLD) or Alzheimer's disease (AD). PPA symptoms are typically assessed qualitatively, which many clinicians believe is valuable but could be improved upon. This study is designed to investigate more objective and efficient methods for assessing PPA and Alzheimer's.

MyndYou's technology uses a unique method for analyzing multiple parameters related to change in cognition that are collected as part of day to day life, among them speech. This study uses MyndYou's platform to test alternative, quantitative assessment options that could lead to an increase in screening accuracy and allow objective detection of sensitive changes in cognition and the tailoring of care in accordance with findings.

Dr. Bradford Dickerson states: "We see a great need for tools that can increase effective and personalized care without disrupting the day-to-day life of our patients. This is only the beginning of our relationship with MyndYou, as we hope their technology will shift the way we care for early stage Cognitive Impairment."

Ruth Poliakine, MyndYou CEO, states: "It is an incredible opportunity to be working with Mass General Hospital and the leading researchers in the arena of Dementia and Alzheimer's Disease. We are excited about this partnership and look forward to making an impact in the field of cognitive care."

About MyndYou: MyndYou is an artificial intelligence (AI) -based platform designed to aid clinicians in tracking and treating cognitive decline among a growing senior population.  MyndYou combines one-on-one remote interaction with a seamless monitoring app, analytic evaluation, and artificial intelligence (AI) analysis to individualize treatment based on real objective data.  For more than 150 million older adults living with Alzheimer's and other types of Dementia, MyndYou helps bridge the gap between safety and independence while maximizing care and quality-of-life.


Scott Eisenstein

212 810 6544


View original content:


PR Newswire

Last updated on: 25/07/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.